Income StatementBalance SheetCash FlowSegments
AbbVie logo

AbbVie Cash Flow Statement

Operating, investing, and financing cash movements

AbbVie generated $21.2B in operating cash flow over the trailing twelve months. After $1.2B in capital expenditures, free cash flow was $20.0B. Free cash flow increased 0.3% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$21.2BNet Cash From Investing (TTM)-$6.5BNet Cash From Financing (TTM)-$10.5BCapital Expenditures (TTM)$1.2BDepreciation And Amortization Cf (TTM)$762.0MNet Change In Cash (TTM)$4.2B
Latest FilingQ1 2026
Report Date2026-05-08
Market Cap$381.10B
P/E Ratio104.84
ROE-139.97%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Non-cash litigation reserve adjustments$167.0M-$729.0M-$21.0M-$319.0M—$150.0M
Other non-cash income (expense)—-$17.0M-$79.0M$90.0M$9.0M$22.0M
Payment for contingent consideration liability (operating)$539.0M$549.0M$859.0M$776.0M$681.0M$722.0M
Other non-cash income (expense)—-$17.0M-$79.0M$90.0M$9.0M$22.0M
Change in accounts payable$1.2B-$696.0M—$1.7B—-$1.6B
Change in accounts receivable-$387.0M$1.5B$17.0M$156.0M—-$87.0M
Change in inventories$128.0M$155.0M$56.0M$0.0$25.0M$184.0M
Deferred income taxes-$767.0M-$28.0M-$272.0M—-$385.0M$137.0M
Other Non-Cash Income (Expense)—-$17.0M-$79.0M$90.0M$9.0M$22.0M
Other Non-cash Income (Expense)—-$17.0M-$79.0M$90.0M$9.0M$22.0M
Other Non-cash Income (Expense)—-$17.0M-$79.0M$90.0M$9.0M$22.0M
Net cash from operating activities$7.0B$1.6B$5.2B$7.0B$5.2B$3.8B
Net income$0.0$1.3B$941.0M$188.0M$1.8B$697.0M
Other non-cash income (expense)—-$17.0M-$79.0M$90.0M$9.0M$22.0M
Amortization of capitalized software and acquired intangible assets$1.9B$1.9B$1.9B$1.9B$1.8B$1.7B
Contingent consideration fair value adjustments$279.0M$1.5B$2.8B$776.0M$1.4B$2.4B
Depreciation$206.0M$181.0M$186.0M$192.0M$203.0M$188.0M
Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable-$1.8B$378.0M-$1.4B-$411.0M—-$81.0M
Increase (Decrease) in Prepaid Expense and Other Assets—$628.0M——$658.0M$150.0M
Other Noncash Income (Expense)—-$17.0M-$79.0M$90.0M$9.0M$22.0M
Other Non-cash Income and Expense—-$17.0M-$79.0M$90.0M$9.0M$22.0M
Other Non-Cash Adjustments—-$17.0M-$79.0M$90.0M$9.0M$22.0M
Other Non-Cash Income and Expense—-$17.0M-$79.0M$90.0M$9.0M$22.0M
Stock-based compensation$164.0M$410.0M$179.0M$209.0M$157.0M$444.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Repayments of other short-term debt—$0.0$0.0$2.0B$791.0M$2.0B
Repayments of Other Short-Term Debt—$0.0$0.0$2.0B$791.0M$2.0B
Repayments of other short-term debt—$0.0$0.0$2.0B$791.0M$2.0B
Proceeds from issuance of debt$2.0B$4.0B———$8.0B
Dividends paid$2.8B$2.9B$2.9B$2.9B$2.9B$3.1B
Other, net$1.0M$67.0M—$37.0M—$2.0M
Proceeds from (repayments of) short-term borrowings, net$0.0$1.6B———-$499.0M
Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security$5.8B$3.0B$3.8B$9.0M$8.0M$0.0
Repayments of Other Short-Term Debt—$0.0———$2.0B
Payment of Deferred Purchase Consideration$0.0$67.0M-$35.0M$37.0M-$69.0M$2.0M
Noncontrolling interest transactions and other$1.0M$67.0M—$37.0M—$2.0M
Repayments of Other Short-term Debt—$0.0$0.0$2.0B$791.0M$2.0B
Net cash from financing activities-$6.9B-$1.3B-$2.7B-$4.6B-$4.2B$919.0M
Noncontrolling Interests Activity and Other$1.0M$67.0M—$37.0M—$2.0M
Repayments of Other Short-Term Debt—$0.0$0.0$2.0B$791.0M$2.0B
Repurchases of common stock$358.0M$961.0M$12.0M$4.0M$3.0M$1.5B
Repayments of Other Short-Term Debt—$0.0$0.0$2.0B$791.0M$2.0B
Repayments of other short-term debt—$0.0$0.0$2.0B$791.0M$2.0B

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired—$204.0M———$0.0
Capital expenditures$291.0M$235.0M$269.0M$381.0M$329.0M$265.0M
Payment for (Proceeds from) Other Investing Activity-$197.0M-$38.0M-$11.0M$77.0M$1.0M$43.0M
Payments to Acquire Other Investments$1.8B$334.0M$940.0M$2.8B$1.2B$266.0M
Net cash from investing activities-$1.9B-$735.0M-$1.2B-$3.3B-$1.5B-$574.0M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$6.8B$1.4B$4.9B$6.6B$4.9B$3.6B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$46.0M$9.0M$30.0M—$11.0M-$12.0M
Net increase (decrease) in cash-$1.7B-$349.0M$1.3B-$838.0M-$400.0M$4.2B

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Interest paid$702.8M$750.5M$750.5M$750.5M$750.5M—